ResearchSpace

Targeted nanodrug delivery systems for the treatment of Tuberculosis

Show simple item record

dc.contributor.author Lemmer, Yolandy
dc.contributor.author Semete, B
dc.contributor.author Booysen, L
dc.contributor.author Kalombo, Lonji
dc.contributor.author Katata, L
dc.contributor.author Jones, AT
dc.contributor.author Alexander, C
dc.contributor.author Khati, M
dc.contributor.author Swai, HS
dc.contributor.author Verschoor, JA
dc.date.accessioned 2010-12-06T10:19:48Z
dc.date.available 2010-12-06T10:19:48Z
dc.date.issued 2010-06
dc.identifier.citation Lemmer, Y, Semete, B, Booysen, L et al. 2010. Targeted nanodrug delivery systems for the treatment of Tuberculosis. 3rd International CDTM symposium, Cardiff, UK, 26-28 June 2010, pp 1 en
dc.identifier.uri http://hdl.handle.net/10204/4597
dc.description 3rd International CDTM symposium, Cardiff, UK, 26-28 June 2010 en
dc.description.abstract South Africa currently has the highest incidence of TB per 100000 (358 per 100000) people in the world. In 2007 alone 112000 people died of TB in South Africa, of which 94 000 (72%) were co-infected with HIV. Although TB treatments exist, poor patient treatment compliance and drug resistance pose a great challenge to TB treatment programs worldwide. To improve the current inadequate therapeutic management of TB, a polymeric anti-TB nanodrug delivery system for anti-TB drugs was developed that may enable entry, targeting, sustained release over long periods and uptake of the antibiotics in the cells, hence reducing the dose frequency and simultaneously improving patient compliance. en
dc.language.iso en en
dc.relation.ispartofseries POSTER en
dc.subject Tuberculosis en
dc.subject Nanodrug delivery systems en
dc.subject TB treatments en
dc.subject Anti-TB drugs en
dc.subject Patient compliance en
dc.title Targeted nanodrug delivery systems for the treatment of Tuberculosis en
dc.type Conference Presentation en
dc.identifier.apacitation Lemmer, Y., Semete, B., Booysen, L., Kalombo, L., Katata, L., Jones, A., ... Verschoor, J. (2010). Targeted nanodrug delivery systems for the treatment of Tuberculosis. http://hdl.handle.net/10204/4597 en_ZA
dc.identifier.chicagocitation Lemmer, Yolandy, B Semete, L Booysen, Lonji Kalombo, L Katata, AT Jones, C Alexander, M Khati, HS Swai, and JA Verschoor. "Targeted nanodrug delivery systems for the treatment of Tuberculosis." (2010): http://hdl.handle.net/10204/4597 en_ZA
dc.identifier.vancouvercitation Lemmer Y, Semete B, Booysen L, Kalombo L, Katata L, Jones A, et al, Targeted nanodrug delivery systems for the treatment of Tuberculosis; 2010. http://hdl.handle.net/10204/4597 . en_ZA
dc.identifier.ris TY - Conference Presentation AU - Lemmer, Yolandy AU - Semete, B AU - Booysen, L AU - Kalombo, Lonji AU - Katata, L AU - Jones, AT AU - Alexander, C AU - Khati, M AU - Swai, HS AU - Verschoor, JA AB - South Africa currently has the highest incidence of TB per 100000 (358 per 100000) people in the world. In 2007 alone 112000 people died of TB in South Africa, of which 94 000 (72%) were co-infected with HIV. Although TB treatments exist, poor patient treatment compliance and drug resistance pose a great challenge to TB treatment programs worldwide. To improve the current inadequate therapeutic management of TB, a polymeric anti-TB nanodrug delivery system for anti-TB drugs was developed that may enable entry, targeting, sustained release over long periods and uptake of the antibiotics in the cells, hence reducing the dose frequency and simultaneously improving patient compliance. DA - 2010-06 DB - ResearchSpace DP - CSIR KW - Tuberculosis KW - Nanodrug delivery systems KW - TB treatments KW - Anti-TB drugs KW - Patient compliance LK - https://researchspace.csir.co.za PY - 2010 T1 - Targeted nanodrug delivery systems for the treatment of Tuberculosis TI - Targeted nanodrug delivery systems for the treatment of Tuberculosis UR - http://hdl.handle.net/10204/4597 ER - en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record